SK

Shinichi Koizumi

AS Askat: 7 patents #2 of 21Top 10%
RP Raqualia Pharma: 6 patents #8 of 69Top 15%
NA Novartis Ag: 5 patents #875 of 5,128Top 20%
CI Ciba-Geigy: 1 patents #1,572 of 2,867Top 55%
CH Cj Healthcare: 1 patents #29 of 86Top 35%
HI Hk Inno.N: 1 patents #16 of 53Top 35%
📍 Ebeye: #192 of 4,528 inventorsTop 5%
Overall (All Time): #220,067 of 4,157,543Top 6%
20
Patents All Time

Issued Patents All Time

Showing 1–20 of 20 patents

Patent #TitleCo-InventorsDate
11840530 Selective EP4 receptor antagonistic substance for treatment of cancer Yukinori Take, Takako Okumura, Kazuhiko Nonomura 2023-12-12
11033532 Uses of benzimidazole derivative for nocturnal acid breakthrough Ha Jin LEE, Bong Tae Kim, Hyun-Joong Kim, Ji Yeon NAM, Jie Eun Park +4 more 2021-06-15
10947235 Selective EP4 receptor antagonistic substance for treatment of cancer Yukinori Take, Takako Okumura, Kazuhiko Nonomura 2021-03-16
10611761 Selective EP4 receptor antagonistic substance for treatment of cancer Yukinori Take, Takako Okumura, Kazuhiko Nonomura 2020-04-07
10583129 Use of EP4 receptor antagonists for the treatment of NASH-associated liver cancer Naoko Ohtani, Fumitaka KAMACHI, Tze Mun Loo, Takako Okumura 2020-03-10
10512635 Uses of benzimidazole derivative for nocturnal acid breakthrough Ha Jin LEE, Bong Tae Kim, Hyun-Joong Kim, Ji Yeon NAM, Jie Eun Park +4 more 2019-12-24
10342785 Use of EP4 receptor antagonists for the treatment of NASH-associated liver cancer Naoko Ohtani, Fumitaka KAMACHI, Tze Mun Loo, Takako Okumura 2019-07-09
9901571 Tetrahydropyrazolopyridine derivatives as ghrelin receptor agonists Yasuhiro Iwata, Kiyoshi Kawamura, Masaki Sudo, Kaoru Shimada, Nobuyuki Takahashi +2 more 2018-02-27
9873695 Serine derivatives as ghrelin receptor agonists Yasuhiro Iwata, Kiyoshi Kawamura, Masaki Sudo, Kaoru Shimada, Nobuyuki Takahashi +2 more 2018-01-23
9688674 Selective EP4 receptor antagonistic substance for treatment of cancer Yukinori Take, Takako Okumura, Kazuhiko Nonomura 2017-06-27
9561210 Therapeutic agent for ocular disease Takako Okumura, Hideaki Hara 2017-02-07
9457084 Use of EP4 receptor antagonists in the treatment of IL-23 mediated diseases Kiyoshi Kanazawa, Kazuhiko Nonomura, Takako Okumura 2016-10-04
8921391 Selective EP4 receptor antagonistic substance for treatment of cancer Yukinori Take, Takako Okumura, Kazuhiko Nonomura 2014-12-30
8648080 Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility Nobuyuki Takahashi 2014-02-11
8034810 Arylsulfonamido-substituted hydroxamic acid derivatives Werner Breitenstein, Kenji Hayakawa, Genji Iwasaki, Takanori Kanazawa, Tatsuhiko Kasaoka +3 more 2011-10-11
7659293 α-Amino-N-hydroxy-acetamide derivatives Kenji Hayakawa, Genji Iwasaki, Ichiro Umemura 2010-02-09
7291634 α-amino-N-hydroxy-acetamide derivatives Kenji Hayakawa, Genji Iwasaki, Ichiro Umemura 2007-11-06
7138432 Arylsulfonamido-substituted hydroxamic acid derivatives Werner Breitenstein, Kenji Hayakawa, Genji Iwasaki, Takanori Kanazawa, Tatsuhiko Kasaoka +3 more 2006-11-21
7112611 1g(α)-amino-N-hydroxy-acetamide derivatives Kenji Hayakawa, Genji Iwasaki, Ichiro Umemura 2006-09-26
5541310 Herbicide resistant plants Eric R. Ward, Sandra Volrath, Sachiyo Tada, Ichiro Mori, Genji Iwasaki 1996-07-30